DUPONT CAPITAL MANAGEMENT CORP - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 35 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$8,333
+316.6%
33,3320.0%0.00%
Q3 2022$2,000
-33.3%
33,3320.0%0.00%
Q2 2022$3,000
-57.1%
33,3320.0%0.00%
Q1 2022$7,000
-65.0%
33,3320.0%0.00%
-100.0%
Q4 2021$20,000
+5.3%
33,3320.0%0.00%0.0%
Q3 2021$19,000
-40.6%
33,3320.0%0.00%0.0%
Q2 2021$32,00033,3320.00%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 133,332$39,7330.09%
ANGELO GORDON & CO., L.P. 13,333$134,6630.02%
Radcliffe Capital Management, L.P. 66,566$672,3170.02%
Dryden Capital, LLC 15,000$4,4700.01%
METEORA CAPITAL, LLC 50,000$14,9000.00%
Arena Capital Advisors, LLC- CA 19,251$5,7370.00%
MMCAP International Inc. SPC 73,525$21,9100.00%
PERISCOPE CAPITAL INC. 196,896$57,5710.00%
MARSHALL WACE, LLP 36,056$364,1650.00%
CLEAR STREET LLC 217,000$650.00%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders